Unlocking the Power of Proteomics with SPOC
Unlocking the Power of Proteomics with SPOC
SPOC Proteomics is Set to Revolutionize Proteomics with High Plex Protein Biosensor Platform
SPOC Proteomics is Set to Revolutionize Proteomics with High Plex Protein Biosensor Platform
SPOC Proteomics is pioneering a new era of proteomics with its innovative sensor-integrated proteome-on-chip (SPOC) technology. By offering unparalleled speed, scale, and data depth, SPOC is set to accelerate drug discovery, biomarker identification, and diagnostics.
SPOC Proteomics is pioneering a new era of proteomics with its innovative sensor-integrated proteome-on-chip (SPOC) technology. By offering unparalleled speed, scale, and data depth, SPOC is set to accelerate drug discovery, biomarker identification, and diagnostics.
About SPOC Proteomics
About SPOC Proteomics
SPOC Proteomics is a deep-tech life sciences startup that has developed a transformative new proteomic biosensor platform termed sensor-integrated proteome-on-chip (SPOC). SPOC Proteomics offers the world’s first and only platform that provides simultaneous quantitative, qualitative, and kinetic data in a single assay at scale, to support drug and vaccine development, protein biomarker discovery, and diagnostics.
SPOC Proteomics is a deep-tech life sciences startup that has developed a transformative new proteomic biosensor platform termed sensor-integrated proteome-on-chip (SPOC). SPOC Proteomics offers the world’s first and only platform that provides simultaneous quantitative, qualitative, and kinetic data in a single assay at scale, to support drug and vaccine development, protein biomarker discovery, and diagnostics.
7201 E Henkel Way Suite 285 Scottsdale, AZ 85255
7201 E Henkel Way Suite 285 Scottsdale, AZ 85255
About SPOC Proteomics
+2,400
+2,400
full-length folded proteins on 1.5 SQ-CM Biosensor Chip
full-length folded proteins on 1.5 SQ-CM Biosensor Chip
SPOC enables up to 2400 unique full-length folded proteins per single biosensor chip, for simultaneous analysis using surface plasmon resonance (SPR) and up to 10,000 protein targets per chip for mass spectrometry analysis. SPOC chip proteins are produced in ~4 hours from an array of plasmid DNA with cell-free human lysate and simultaneously captured directly onto biosensor chip surfaces.
SPOC enables up to 2400 unique full-length folded proteins per single biosensor chip, for simultaneous analysis using surface plasmon resonance (SPR) and up to 10,000 protein targets per chip for mass spectrometry analysis. SPOC chip proteins are produced in ~4 hours from an array of plasmid DNA with cell-free human lysate and simultaneously captured directly onto biosensor chip surfaces.
This unique protein production method circumvents challenges and expense of traditional recombinant protein workflows, reducing costs 10-100x and substantially decreasing production time. Our mission is to utilize SPOC to democratize high-throughput kinetic proteomic screens and facilitate early disease detection – ultimately enabling disease preemption.
This unique protein production method circumvents challenges and expense of traditional recombinant protein workflows, reducing costs 10-100x and substantially decreasing production time. Our mission is to utilize SPOC to democratize high-throughput kinetic proteomic screens and facilitate early disease detection – ultimately enabling disease preemption.
Meet our leadership team
Meet our leadership team
SPOC Proteomics is pioneering a new era of proteomics with its innovative sensor-integrated proteome-on-chip (SPOC) technology. By offering unparalleled speed, scale, and data depth, SPOC is set to accelerate drug discovery, biomarker identification, and diagnostics.
SPOC Proteomics is pioneering a new era of proteomics with its innovative sensor-integrated proteome-on-chip (SPOC) technology. By offering unparalleled speed, scale, and data depth, SPOC is set to accelerate drug discovery, biomarker identification, and diagnostics.
Leadership
Leadership
Bharath Takulapalli, PhD
Bharath is inventor of multiple foundational life science technologies designed to extract 1000x more information from biological systems. He conceived SPOC platform for democratizing proteomics, and FENT CMOS-nanopore technology for ultra-fast DNA sequencing. Bharath has B.Tech from IIT Madras and PhD from Arizona State University.
Founder & CEO
Mukilan Mohan, MS MBA
At SPOC, Mukil is responsible for business operations and finance, co-owns product and strategy. He previously led product management and system design functions for revops systems at TD-Ameritrade’s investor education division. Prior to that, he held multiple consulting roles in IT and management. He has an MS (EE) & an MBA from ASU
Co-Founder & COO
Dr. Lydia Gushgari
Dr. Lydia Gushgari has 10 years’ experience in immunology, virology, infectious diseases, vaccine development, melanoma, clinical laboratory diagnostic immunology, and autoimmunity. Lydia completed her Doctoral studies at Arizona State University, studying plant-produced vaccines and attenuated viral vaccine vectors for HIV.
Director of Clinical Research & Chief of Staff
Bharath Takulapalli, PhD
Founder & CEO
Bharath is inventor of multiple foundational life science technologies designed to extract 1000x more information from biological systems. He conceived SPOC platform for democratizing proteomics, and FENT CMOS-nanopore technology for ultra-fast DNA sequencing. Bharath has B.Tech from IIT Madras and PhD from Arizona State University.
Mukilan Mohan, MS MBA
Co-Founder & COO
At SPOC, Mukil is responsible for business operations and finance, co-owns product and strategy. He previously led product management and system design functions for revops systems at TD-Ameritrade’s investor education division. Prior to that, he held multiple consulting roles in IT and management. He has an MS (EE) & an MBA from ASU
Dr. Lydia Gushgari
Director of Clinical Research & Chief of Staff
Dr. Lydia Gushgari has 10 years’ experience in immunology, virology, infectious diseases, vaccine development, melanoma, clinical laboratory diagnostic immunology, and autoimmunity. Lydia completed her Doctoral studies at Arizona State University, studying plant-produced vaccines and attenuated viral vaccine vectors for HIV.
Bharath Takulapalli, PhD
Founder & CEO
Bharath is inventor of multiple foundational life science technologies designed to extract 1000x more information from biological systems. He conceived SPOC platform for democratizing proteomics, and FENT CMOS-nanopore technology for ultra-fast DNA sequencing. Bharath has B.Tech from IIT Madras and PhD from Arizona State University.
Mukilan Mohan, MS MBA
Co-Founder & COO
At SPOC, Mukil is responsible for business operations and finance, co-owns product and strategy. He previously led product management and system design functions for revops systems at TD-Ameritrade’s investor education division. Prior to that, he held multiple consulting roles in IT and management. He has an MS (EE) & an MBA from ASU
Dr. Lydia Gushgari
Director of Clinical Research & Chief of Staff
Dr. Lydia Gushgari has 10 years’ experience in immunology, virology, infectious diseases, vaccine development, melanoma, clinical laboratory diagnostic immunology, and autoimmunity. Lydia completed her Doctoral studies at Arizona State University, studying plant-produced vaccines and attenuated viral vaccine vectors for HIV.
Board of directors and Scientific Advisory Board
Dr. George Church - Professor of Genetics
Dr. George Church is professor of Genetics at Harvard Medical School and director of Personal Genome Project. His 1984 Harvard PhD included the first methods for direct genome sequencing and molecular multiplexing, which helped initiate the Human Genome Project.
Harvard Medical School
Dr. Chenming Hu – Professor of EECS
Dr. Chenming Hu, Professor Emeritus of EECS at UC Berkeley,visionary inventor of the FinFET. He is a world’s foremost authority on CMOS device physics, modeling and manufacturing. Intel began commercializing the 3D transistor based chips in 2011, with most others following soon.
University of California, Berkeley
Dr. Joshua LaBaer – Director, Center for Personalized Medicine
Dr. Joshua LaBaer is the Director of Virginia Piper center for personalized diagnostics at the Biodesign Institute ASU, home to DNASU plasmid repository and the Sequencing Core. He is a medical oncologist, cancer researcher and nation’s leading proteomics expert.
ASU Biodesign Institute
Dr. Abhay Sanan – President, Center for Neurosciences
Dr. Abhay Sanan is a Neurosurgeon with more than 24 years of experience in broad areas of neurosciences. He is the lead investor and a member of the Board of Directors at SPOC. He understands how technology drives healthcare outcomes and invests in paradigm changing technologies.
Center for Neurosciences, Tucson
Jean Pierre Millon, MBA
JP Millon currently serves on the board of CVS Health that combines CVS Pharmacy, Caremark, Minute Clinic and CVS Specialty. He is the former President and Chief Executive Officer of PCS Health Systems Inc. He previously served on the boards of Caremark Rx and Advance PCS.
DIRECTOR
Dr. George Church - Professor of Genetics
Harvard Medical School
Dr. George Church is professor of Genetics at Harvard Medical School and director of Personal Genome Project. His 1984 Harvard PhD included the first methods for direct genome sequencing and molecular multiplexing, which helped initiate the Human Genome Project.
Dr. Chenming Hu – Professor of EECS
University of California, Berkeley
Dr. Chenming Hu, Professor Emeritus of EECS at UC Berkeley,visionary inventor of the FinFET. He is a world’s foremost authority on CMOS device physics, modeling and manufacturing. Intel began commercializing the 3D transistor based chips in 2011, with most others following soon.
Dr. Joshua LaBaer – Director, Center for Personalized Medicine
ASU Biodesign Institute
Dr. Joshua LaBaer is the Director of Virginia Piper center for personalized diagnostics at the Biodesign Institute ASU, home to DNASU plasmid repository and the Sequencing Core. He is a medical oncologist, cancer researcher and nation’s leading proteomics expert.
Dr. Abhay Sanan – President, Center for Neurosciences
Center for Neurosciences, Tucson
Dr. Abhay Sanan is a Neurosurgeon with more than 24 years of experience in broad areas of neurosciences. He is the lead investor and a member of the Board of Directors at SPOC. He understands how technology drives healthcare outcomes and invests in paradigm changing technologies.
Jean Pierre Millon, MBA
DIRECTOR
JP Millon currently serves on the board of CVS Health that combines CVS Pharmacy, Caremark, Minute Clinic and CVS Specialty. He is the former President and Chief Executive Officer of PCS Health Systems Inc. He previously served on the boards of Caremark Rx and Advance PCS.
Dr. George Church - Professor of Genetics
Harvard Medical School
Dr. George Church is professor of Genetics at Harvard Medical School and director of Personal Genome Project. His 1984 Harvard PhD included the first methods for direct genome sequencing and molecular multiplexing, which helped initiate the Human Genome Project.
Dr. Chenming Hu – Professor of EECS
University of California, Berkeley
Dr. Chenming Hu, Professor Emeritus of EECS at UC Berkeley,visionary inventor of the FinFET. He is a world’s foremost authority on CMOS device physics, modeling and manufacturing. Intel began commercializing the 3D transistor based chips in 2011, with most others following soon.
Dr. Joshua LaBaer – Director, Center for Personalized Medicine
ASU Biodesign Institute
Dr. Joshua LaBaer is the Director of Virginia Piper center for personalized diagnostics at the Biodesign Institute ASU, home to DNASU plasmid repository and the Sequencing Core. He is a medical oncologist, cancer researcher and nation’s leading proteomics expert.
Dr. Abhay Sanan – President, Center for Neurosciences
Center for Neurosciences, Tucson
Dr. Abhay Sanan is a Neurosurgeon with more than 24 years of experience in broad areas of neurosciences. He is the lead investor and a member of the Board of Directors at SPOC. He understands how technology drives healthcare outcomes and invests in paradigm changing technologies.
Jean Pierre Millon, MBA
DIRECTOR
JP Millon currently serves on the board of CVS Health that combines CVS Pharmacy, Caremark, Minute Clinic and CVS Specialty. He is the former President and Chief Executive Officer of PCS Health Systems Inc. He previously served on the boards of Caremark Rx and Advance PCS.
For more information on the SPOC platform, get in touch:
Information
Contact Us
Privacy & Conditions
1600 Adams Drive Suite236 Menlo Park, CA 94025
7201 E Henkel Way, Suite 285 Scottsdale, AZ 85255
480-219-9506
info@spoc.bio
All rights reserved © 2024
For more information on the SPOC platform, get in touch:
Information
Contact Us
Privacy & Conditions
1600 Adams Drive Suite236 Menlo Park, CA 94025
7201 E Henkel Way, Suite 285 Scottsdale, AZ 85255
480-219-9506
info@spoc.bio
All rights reserved © 2024
For more information on the SPOC platform, get in touch:
Information
Contact Us
1600 Adams Drive
Suite236
Menlo Park, CA 94025
7201 E Henkel Way
Suite 285
Scottsdale, AZ 85255
480-219-9506
info@spoc.bio